Topical keratolytics

Definition and Therapeutic Purpose

Topical keratolytics are dermatological agents used to break down and soften the outermost layer of the skin (stratum corneum). These agents help remove excessive keratin, scale, or dead skin cells from the surface of the skin or within hair follicles, promoting skin renewal and enhancing the absorption of other topical therapies. They are frequently employed in the management of acne, psoriasis, warts, corns, calluses, ichthyosis, seborrheic dermatitis, and hyperkeratotic disorders.

These agents are found in creams, ointments, gels, solutions, shampoos, and soaps, and their concentration and formulation are selected based on the skin condition being treated.

---

Mechanism of Action

Topical keratolytics function primarily by:

1. Disrupting intercellular cohesion of corneocytes in the stratum corneum

2. Hydrating the skin and reducing scaling

3. Solubilizing keratin and desmosomal proteins

4. Promoting exfoliation and desquamation

5. Opening clogged pores (in acne-prone skin)

6. Facilitating penetration of other therapeutic agents (e.g., corticosteroids, antimicrobials)

At higher concentrations, some keratolytics also exhibit antimicrobial, anti-inflammatory, or caustic properties.

---

Therapeutic Indications

Topical keratolytics are used in the management of:

• Acne vulgaris

• Psoriasis vulgaris

• Seborrheic dermatitis

• Hyperkeratosis and ichthyosis

• Warts (verrucae)

• Corns and calluses

• Dandruff

• Actinic keratosis (adjunct)

• Palmoplantar keratoderma

• Atopic dermatitis with lichenification

---

Common Generic Names of Topical Keratolytics

1. Salicylic acid

   • Most widely used keratolytic

   • Concentration: 0.5%–6% (for acne and seborrheic dermatitis), up to 40% (for warts and corns)

   • Keratolytic, comedolytic, and mild anti-inflammatory

   • Often combined with sulfur, coal tar, or corticosteroids

2. Urea

   • Concentration-dependent action:

     • ≤10%: Humectant

     • 10–30%: Keratolytic

     • 30%: Proteolytic

   • Breaks hydrogen bonds in keratin

   • Used for xerosis, ichthyosis, hyperkeratosis, calluses, eczema, and nail debridement

3. Lactic acid

   • Alpha hydroxy acid (AHA)

   • Hydrating and keratolytic

   • Enhances desquamation and skin smoothness

   • Common in urea-based emollient products for ichthyosis and keratosis pilaris

4. Glycolic acid

   • AHA used in chemical peels and for photoaging

   • Desquamates corneocytes

   • Also used in acne and keratosis pilaris

5. Benzoyl peroxide

   • Mildly keratolytic

   • Strong oxidizing and antimicrobial agent (particularly against Propionibacterium acnes)

   • Used in acne formulations (2.5%–10%)

6. Resorcinol

   • Used in combination with sulfur or salicylic acid

   • Keratolytic and antiseptic

   • Effective in acne and seborrheic dermatitis

7. Sulfur

   • Mild keratolytic and antimicrobial properties

   • Often combined with salicylic acid or benzoyl peroxide

   • Used in acne, seborrheic dermatitis, rosacea

8. Podophyllotoxin

   • Keratolytic and cytotoxic agent used to treat genital warts

   • Applied in cycles (0.5% solution or cream)

9. Tretinoin (topical retinoid)

   • Indirectly keratolytic by normalizing desquamation

   • Indicated in acne, photoaging, hyperpigmentation

10. Coal tar

    • Has keratoplastic and keratolytic actions

    • Used in psoriasis and eczema

    • Often combined with salicylic acid in ointments and shampoos

11. Zinc pyrithione (less keratolytic, more cytostatic)

    • Used in dandruff shampoos

    • Normalizes keratinocyte turnover

12. Alpha-hydroxy acids (AHAs)

    • Includes glycolic, lactic, citric, malic acids

    • Improve exfoliation, texture, and hydration

---

Formulations and Administration

Topical keratolytics are available as:

• Lotions and creams (face and body)

• Ointments (thicker applications for plaques)

• Solutions and tinctures (warts, corns)

• Shampoos (seborrheic dermatitis, dandruff)

• Gels and foams (scalp or acne lesions)

• Soaps and cleansers (daily use)

Frequency of application depends on concentration and formulation:

• Mild acne: 1–2 times daily

• Psoriasis plaques: once daily to twice weekly

• Warts: once daily or as directed

---

Adverse Effects

1. Local Reactions

   • Erythema

   • Peeling or scaling

   • Burning or stinging sensation

   • Dryness or irritation

   • Photosensitivity (especially with AHAs or retinoids)

   • Contact dermatitis (especially salicylic acid, resorcinol, sulfur)

2. Systemic Toxicity (rare but possible with widespread/high concentration use)

   • Salicylism from excessive salicylic acid (especially in children or broken skin)

   • Resorcinol poisoning (thyroid dysfunction, methemoglobinemia in overuse)

---

Contraindications

• Hypersensitivity to any component

• Open wounds or broken skin (risk of systemic absorption)

• Children under 2 years (especially with salicylic acid or resorcinol)

• Pregnancy and lactation (retinoids and podophyllotoxin are contraindicated)

• Inflamed or infected skin (except under specialist care)

---

Precautions

• Avoid use on mucosal surfaces, eyes, or genital areas unless prescribed

• Use sun protection with AHAs, retinoids, and salicylic acid

• Limit use to localized areas to avoid systemic toxicity

• Taper use if significant irritation occurs

---

Drug Interactions

• Other topical irritants (retinoids, benzoyl peroxide): risk of cumulative irritation

• Photosensitizers (retinoids + AHAs): increased risk of sunburn

• Systemic salicylates or methotrexate: avoid high-dose salicylic acid concurrently

• May enhance penetration of corticosteroids or antibiotics

---

Special Populations

• Pediatrics: Use lower concentrations with caution; avoid extensive areas

• Elderly: Increased skin sensitivity and slower healing

• Pregnancy: Avoid podophyllotoxin, topical retinoids; salicylic acid in moderation

• Lactation: Avoid application to chest area; some agents contraindicated

---

Patient Counseling Points

• Apply to clean, dry skin only

• Start with low concentration, increase gradually

• Apply moisturizer regularly if dryness occurs

• Avoid sun exposure or use high-SPF sunscreen

• Do not occlude unless instructed by a physician

• Expect peeling or flaking—this is part of the treatment response

• Wash hands after application

---

Monitoring Parameters

• Improvement in scaling, plaque thickness, acne severity

• Local skin reaction: redness, irritation, or blistering

• Systemic symptoms (salicylism: tinnitus, nausea, dizziness)

• Treatment tolerance and patient adherence

---

Examples of Commercial Products

Product Name	Generic Ingredient(s)	Indication
Duofilm®, Compound W®	Salicylic acid (12%–40%)	Warts, corns
Keralyt®, Salex®	Salicylic acid (6%–10%)	Psoriasis, dandruff
Eucerin Urea Repair®	Urea (10%–30%)	Dry, scaly skin
Lac-Hydrin®, AmLactin®	Lactic acid	Xerosis, keratosis pilaris
Benzac AC®	Benzoyl peroxide	Acne
Epiduo®	Adapalene + benzoyl peroxide	Acne
Tazorac®	Tazarotene	Psoriasis, acne
Vaniqa®	Eflornithine (not keratolytic, similar topical class)	Hirsutism

Clinical Guidelines and Recommendations

• American Academy of Dermatology (AAD): Keratolytics are part of first-line acne therapy in mild to moderate forms.

• European Academy of Dermatology and Venereology (EADV): Recommends keratolytics for scaling control in psoriasis and as adjunct to phototherapy.

• National Psoriasis Foundation: Endorses urea and salicylic acid for plaque softening and enhancing topical corticosteroid delivery.

• British Association of Dermatologists: Supports use in ichthyosis, palmoplantar keratoderma, and as peeling agents